The deal gives Tanon rights to sell Sygnis's InstantBlue stain and Ultrafast blotting buffer in China and expands on a previous deal covering precast gels.
Though considered potential antibody alternatives, these reagents are more likely to succeed in new applications for which conventional tools are poorly suited.
The company is aiming to uncover the cause of fibromyalgia and to identify new disease-specific genetic biomarkers.
The partners will develop biomarkers and assays to evaluate non-alcoholic steatohepatitis, a disease characterized by liver scarring due to inflammation.
Using a combination of APEX labeling and mass spec, the researchers mapped several GPCR interactomes, which have proved difficult for conventional approaches.
Vivek Murthy is no longer the surgeon general of the US, the Associated Press reports.
People around the globe took to the streets to support science — some with signs.
Parents who learn of their increased genetic risk of disease also contend with telling their children about theirs, the New York Times writes.
In PLOS this week: loci linked to body mass index measurements, long non-coding RNA expression and urothelial carcinoma prognosis, and more.